A detailed history of Clifford Group, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Clifford Group, LLC holds 485 shares of LLY stock, worth $439,754. This represents 0.31% of its overall portfolio holdings.

Number of Shares
485
Previous 485 -0.0%
Holding current value
$439,754
Previous $283 Million 33.46%
% of portfolio
0.31%
Previous 0.26%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$350.74 - $468.98 $170,108 - $227,455
485 New
485 $227 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $862B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Clifford Group, LLC Portfolio

Follow Clifford Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clifford Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clifford Group, LLC with notifications on news.